Multicellular organisms face the necessity of removing superfluous or injured cells during normal development, tissue turn-over and in response to damaging conditions. These finalised killings occur throughout a process, commonly called programmed cell death (PCD), which is placed under strict cellular control. PCD is regulated by the products of the expression of a number of genes. This fact raises the intriguing possibility of inhibiting such degenerative processes by operating on some of the controlling genes. Central neurons of transgenic mice overexpressing bcl-2, a powerful inhibitor of PCD, are remarkably resistant to degeneration induced by noxious stimuli. We have explored the fate of retinal ganglion cells and of their axons, when such transgenic animals have been challenged by a lesion of the optic nerve. These results have direct bearing on the possibility of attaining functional restoration of the injured pathway.
Introduction
The optic nerve has been extensively used to study the degenerative processes started by traumatic injury in the central nervous system. This is so because the optic nerve is rather easily accessible for surgical and pharmacological manipulation and, at the same time, the neurons originating its fibers, the retinal ganglion cells (RGC), are readily recognisable. A traumatic injury to the optic nerve induces the death of the vast majority of the axotomised RGCs: the rapidity and extent of this degenerative process depends critically on the severity of the lesion, on its location along the nerve [31] and on the age of the animal. Recently it has been demonstrated that axotomy starts a process of programmed cell death (PCD) in the RGCs, as clearly shown in retinae of new-borns where the signs of apoptosis (the morphological correlate of PCD) become manifest shortly after nerve section [27] . This demonstration is more difficult to attain in adult retinae, because the death process is spread over a time window of several weeks, and the telltale signs of apoptosis are therefore rather elusive [3, 15] .
The discovery that programmed cell death is implicated in axotomy-induced degeneration is very important because PCD is a regulated process placed under the control of a number of proteins [10, 20, 24] . Therefore we might be able to inhibit the degenerative process by fiddling with some of the regulatory or effector stages. Among the regulatory elements of PCD, the product of the expression of the gene bcl-2 is extremely well maintained in evolution, and it plays a powerful inhibitory role on the death process in organisms as different as C. elegans and man [13] . In vitro studies have shown that bcl-2 has a strong protective effect on neurons when they are challenged by a great variety of injuries, such as growth factor deprivation, hypoxia, excitotoxicity, and so on [1, 18, 33] . This is a remarkable and potentially useful fact, because it implies that the pathways activated by these various injuries do, at least to some extent, converge on some common executioner mechanism, and that bcl-2 plays its inhibitory effect enough downstream to act on all of these pathways.
The protective action of this regulatory gene critically depends on the level of its expression. However, it seems that bcl-2 plays its role only during early development, as a part of the regulatory machinery that controls developmental cell death [17] . Later on in development the physiological levels of bcl-2 expression in the CNS are too low to prevent cell death induced by noxious stimuli. In the past, the protective effects of bcl-2 on central neurons have been studied in in vitro systems where its level had been artificially raised [1, 14] . Recently, Martinou and his associates generated a transgenic mice by inserting in the progenitor genoma a gene coding for human bcl-2 [11, 23] . The transgene is placed under the control of a neuron-specific enolase and bcl-2 is overexpressed in most neurons of the CNS, starting from embryonic day 13. In this review we intend to show how powerful bcl-2 overexpression is in inhibiting programmed cell death in the retina both during development and following optic nerve injury.
Protection of axotomised ganglion cells
Development of the nervous system is accompanied by a diffused process of cell death that is critical for shaping the mature system. All classes of retinal neurons are affected by this natural mortality and, in particular, at least half of the ganglion cells in mice retina die in the first few days of postnatal life. During this time RGCs are extremely vulnerable to a section of the optic nerve, and at least 50% of them die within 24 h from the lesion. The RGCs demise occurs because of the activation of PCD, as demonstrated by the characterisation of the dying neurons [27] . Twenty-four hours after optic nerve transection, RGCs displayed all the typical signs of apoptosis: nuclei were vesciculated with highly condensed chromatin (pyknosis) and the DNA showed a specific fragmentation pattern [12] . Perhaps the most characteristic morphological sign of apoptosis is the fragmentation of the cell in small vesicles which are densely stained by a nuclear dye: Fig. 1B shows this phenomenon in a neonatal wild-type retina 24 h after intracranial section of the optic nerve. The retina of the transgenic mice overexpressing bcl-2 was virtually normal 24 h after surgery (Fig. 1A) .
Ganglion cell degeneration after optic nerve section progresses much more slowly in the adult than in the neonate. For this reason only a small fraction of cells are pyknotic at any time after the section, and it is therefore more difficult to characterise the death process. However, the results we obtained in the immature retinae led us to expect a comparable protective effect of bcl-2 overexpression on the adult transgenic retina. In Fig. 1 , Panels D and F show retinae from a transgenic (D) and wild-type adult donors 3.5 and 2 months after optic nerve section. The comparison of the two panels clearly shows that cell death induced by axotomy is markedly inhibited by the transgene overexpression. Another interesting fact is that the control retina from the transgenic mouse has many more cells than the wild-type retina (compare panels C and E in Fig. 1 ). This is certainly due to the inhibitory effects of bcl-2 overexpression on developmental cell death [4] .
Our data on cell survival are summed up in Fig. 2 . RGCs are similarly numerous in both wild-type and transgenic neonatal mice, but more than half of these cells are lost due to natural cell death that occurs in wild-type mice but not in the transgenic population. For this reason, adult wild-type mice have about onethird of the retinal ganglion cells of transgenic adult mice.
Axotomy has a devastating effect on the immature retina, while no significant loss occurs in the transgenic animals at least in the first 24 h after lesion. When the nerve section is performed in adult transgenic mice it In each panel, the label Newborn indicates data from P1-2 mice, 24 h after section. The survival for the adult mice was 2 and 3.5 months for the wild-type and transgenic animals, respectively. Countings have been corrected for the population of displaced amacrine cells as explained elsewhere [4, 7] . Error bars indicate standard deviation, numbers in parentheses indicate the number of retinae analysed in each group. genic mice, up to the point that the centre-periphery gradient was reverted. This observation might be explained by the following argument: Villegas-Péres et al. [31] observed that RGC vulnerability to optic nerve section was inversely proportional to the distance of the lesion from the retina. In our conditions the section is performed about 3 mm from the optic disk, therefore peripheral neurons are twice as far from the section site than neurons at the center of the retina [7] .
Preservation of retinal function
We wondered whether the surviving cells were still functionally connected to the incoming visually driven synaptic input, and whether they had some residual electrophysiological activity. Fig. 4 shows the electroretinogram evoked by a patterned stimulation (P-ERG), as measured by corneo-scleral electrodes placed under the eyelids. A and B in Fig. 4 show the recordings from the control eye of a wild-type (A) and a transgenic mouse (B) obtained 2 and 3.5 months, respectively, after surgery. The wave form, which is known to depend on the RGC electrical activity [22] , Fig. 3 . Isodensity maps of all neurons in the ganglion cell layer of two pairs of retinae, from transgenic (top pair) and wild-type mice (bottom pair). The control retinae, controlateral to the lesioned optic nerve, are shown on the left, while lesioned retinae 3.5 (top) and 2 months (bottom) after optic nerve transection are shown on the right. The shift from one grey level to the adjacent indicates a 5% change in cell density with respect to the peak density of the corresponding unlesioned retina. Most of the cells seen in the wild-type retina after section are displaced amacrine cells. The peak density of the transgenic and wild-type retinae were 16600 and 11600 cells/mm 2 , respectively. The label N indicates the nasal quadrant of each retina. Dorsal side is up. The calibration bar is 3 mm. appears that bcl-2 protection is not complete, at least when long post-surgical survivals are involved, since 30% of RGCs were found to be dead 3.5 months after lesion. However, this mortality is vastly inferior to the one observed in the wild-type animal, where 95% of cells died in a period of 2 months after lesion [7] .
It is interesting to look at the distribution of the surviving neurons in the retina: Fig. 3 shows the isodensity maps for the retinae from wild-type and transgenic mice. It is clear that the control transgenic retina (upper left panel) displayed a much higher cell density (see legend for numerical details) and that the center to periphery gradient was less defined than in the wildtype retina (lower left panel). After lesion of the optic nerve, the wild-type retina appeared very depleted (lower right panel), much more so than the retina from the transgenic (upper right). The majority of cell loss occurred in the central area of the retina of the trans- contrast with the situation usually met in the central nervous system, where an almost complete loss of neurons is the normal response to a traumatic injury. In our view, the obvious question to ask at this point is: is this system capable of regeneration at all? On one hand, it is tempting to answer that, whatever intrinsic regenerative capability were present in central neurons, this system should maximise the chances for regeneration, since it is not limited by cell death. On the other hand, it is clear that much more than survival is necessary for regeneration.
Indeed the lack of regeneration in the mammalian CNS is due to a combination of factors, most of them still poorly understood, and not only to the high mortality of the injured cells. A key element on the road to regeneration is the modification of the environment that has to be crossed by the regenerating fibers. This case is clearly illustrated by a difficult experiment performed by the group led by Albert Aguayo [30] , where they showed some regeneration toward target, once a more permissive environment (peripheral nerve graft) was offered to RGCs for their axons to grow. Therefore it is certainly naive to expect major regeneration from the bcl-2 system unless additional measures are taken to confront the inhibitory characteristics of the environment. One class of inhibitory factors has been characterised by Schwab and collaborators, who identified myelin-associated proteins that, on binding with a receptor on the growth cones, inhibit the fiber elongation. These proteins are thought to be the main inhibitory factors present on the central myelin. The Swiss group purified an antibody, named IN-1, that binds the inhibitory proteins and neutralises their effect [6] . In a number of elegant in vivo and in vitro experiments, the authors showed that this simple treatment makes the central myelin far less inhibitory on regenerating fibers [5, 29, 32] .
The neutralising antibody is produced by a line of hybridoma cells, that can be implanted in small containers placed nearby the lesioned nerves. Fig. 6A shows a cross-section of one capsule filled with hybridoma cells that proliferated rapidly and invaded the available volume. One problem of this strategy of implant is that the antibodies are large molecules that penetrate very little into the tissue. A potential solution to this problem could be to transplant the hybridoma cells directly into the nerve nearby the lesion site, as shown in Fig. 6B . Further enhancement of the regenerative capabilities of the lesioned neurons could be obtained by co-transplant of Schwann cells that are known to produce a number of trophic factors, and to participate in maintenance and repair in the peripheral nervous system [9, 25] . We are following all these avenues, but it is too early to tell how successful these strategies will be. appeared quite similar in the two control eyes. The situation was drastically different in the eyes on the operated side: the P-ERG of the bcl-2 retina was virtually identical to control, whereas the wild-type retina was totally unresponsive [26] .
These data show that bcl-2 overexpression protected the cell body from degeneration, and that the dendrites were, at least to some extent, still present and capable of receiving and integrating synaptic inputs. Furthermore, the membrane properties must have been sufficiently preserved in order to maintain the electrophysiological activity. Therefore cell body and dendritic arborisation of the injured neurons were relatively unaffected by the lesion. But what about the proximal segment of the sectioned axons? Fig. 5 shows the appearance of the optic nerve nearby the emergence from the eye, as seen by electron microscopy. The wild-type nerve was clearly degenerated with only very few surviving fibers, which were surrounded by degenerating myelinic sheaths. Most of the space previously occupied by myelinated fibers has been invaded by hypertrophic astrocytes. Once again, the situation was much better in the stump of the transgenic nerve. There was a large number of surviving fibers still sheeted in a normally looking myelinic envelope. Gliosis appeared to be much reduced if present at all [7] .
Axonal regeneration
In summary, we have described a model where central neurons survive for several months after axotomy, they maintain functionality and connectivity, and at least the proximal segment of their axons keeps a relatively normal ultrastructure. This is in profound Fig. 5 . Electron micrograph of the proximal stump of the optic nerve of a wild-type (A) and transgenic mouse (B). The survival times after surgery were 2 and 3.5 months for (A) and (B), respectively. The star indicates an hypertrophic astrocytic process, and the arrowhead points to a large diameter fiber surrounded by a degenerating myelinic sheet. The calibration bar is 1 mm. Methods as described by Cenni et al. [7] . Fig. 7 shows a transgenic nerve 3 months after the crush and simultaneous implantation of a capsule filled with hybridoma cells on the lesioned nerve (A). Many surviving fibers can be seen sprouting nearby the lesion site (C). Some fibers succeeded in escaping from the crush site and reached the chiasm (B). Similar regenerating fibers have been found by Weibel et al. [32] , who crushed the optic nerve of young (P16-18) rats and implanted encapsulated IN-1 hybridoma cells over the lesioned nerve. However, our experimental paradigm has important differences. We observed regenerating fibers and vigorous sprouting a long time after the lesion (over 3 months) in adult mice. In the earlier experiment, much younger animals were used (presumably because regeneration proceeds more rapidly) and the RGCs had to be supplemented by endogenous factors in order to keep them viable. Such a treatment was not necessary in the bcl-2 overexpressing mice. Nerves from similarly treated wildtype donors failed to show significative regeneration.
Bcl-2 overexpression could have other actions on regeneration beyond the effect due to the improved survival of the injured neurons. Recent results suggest that the Bcl-2 protein may play its protective role by antagonising rises in cytosolic free calcium due to the release from internal stores [16, 21, 28] . This may have a direct bearing on the problem of regeneration, since growth cone motility is known to depend critically on Ca levels [19] . In addition, also the myelin inhibitory action is mediated by calcium changes: contact of the growth cone with the myelin inhibitory protein causes a large Ca release from internal stores, and this event is rapidly followed by the collapse of the growth cone [2] . The prevention of calcium release, and the resultant stabilisation of cytosolic calcium concentration, was sufficient to prevent the collapse of the growth cone. Therefore, it is quite conceivable that bcl-2 overexpression, acting on Ca homeostasis, might enhance the regenerative capabilities of the lesioned axons. Indeed, an in vitro experiment by Chen et al. [8] demonstrated that neurons from bcl-2 overexpressing donors grew a rich plexus of neurites on an embryonic tectum slice. When neurons from wild-type mice were cultured in similar conditions, they failed to produce substantial outgrowth. 
